Nanostring Technologies

Develops products that unlock genomic information from tissue and enable scientists and clinicians to create tests to improve patient care. Its first offering in the molecular diagnostics market, the Prosigna Breast Cancer Assay, received EU regulatory clearance last year. The company filed to go public in May 2013.

2013 Inc. 5000 Rank:
# 1783
Leadership:
R. Bradley Gray
2012 Revenue:
$ 23 Million
3-Year Growth:
215%
Industry:
Health
Location:
SeattleWA 
Founded:
2003
Employees:
138

MORE COMPANY INFORMATION